CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). The company is headquartered in Tuebingen, Baden-Wuerttemberg and currently employs 825 full-time employees. The firm was founded in 2020.
Industry: Pharmaceutical Preparations Peers: Affimed N.V. Biontech SE Immatics NV Mainz Biomed NV
Loading...
